WARREN, N.J. — GlaxoSmithKline (GSK) announced Friday the appointment of Rachel Marler as the new Chief Customer Officer, US. In her role, Marler will lead GSK Consumer Health’s customer engagement efforts to build strong, trusting retailer partnerships and deliver compelling category and shopper healthcare experiences across the customer channels. She is a U.S. leadership team
OMAHA, Neb. – Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions announce today their available services for GlaxoSmithKline’s infused medication sotrovimab. Sotrovimab is a monoclonal antibody treatment that has received the FDA’s emergency use authorization, or EUA, for the treatment of mild to moderate COVID-19 in adults and pediatric patients. Sotrovimab is authorized to treat patients (12
WARREN, N.J. — The Food and Drug Administration has approved Voltaren Arthritis Pain as an over-the-counter remedy for arthritis pain, GlaxoSmithKline said Tuesday. With the FDA’s approval, Voltaren Arthritis Pain becomes the first and only prescription strength, nonsteroidal anti-inflammatory (NSAID) topical gel for arthritis pain available O-T-C in the United States. Voltaren Gel, which GSK Consumer
WARREN, N.J. — GlaxoSmithKline said Thursday that it has closed a previously announced joint venture deal with Pfizer Inc. that will combine their respective consumer healthcare businesses. The move will create the world’s largest supplier of over-the-counter medications. The joint venture company will operate as GSK Consumer Healthcare. Pfizer owns a 32% equity stake in